
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Prism Biolab
Deal Size : Undisclosed
Deal Type : Collaboration
Elix and PRISM BioLab Collaborate to Accelerate AI-Driven Drug Discovery
Details : Elix's AI discovery platform will be integrated with PRISM PepMetics technology. The collaboration will expand the scope of AI-driven exploration to include previously unconsidered small molecules.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 15, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Prism Biolab
Deal Size : Undisclosed
Deal Type : Collaboration
